• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . A biomathematical model of SARS-CoV-2 in Syrian hamsters

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Dec 18;14(1):30541.
doi: 10.1038/s41598-024-80498-9. A biomathematical model of SARS-CoV-2 in Syrian hamsters

Sibylle Schirm[SUP] 1 [/SUP], Geraldine Nouailles[SUP] 2 [/SUP], Holger Kirsten[SUP] 3 [/SUP], Jakob Trimpert[SUP] 4 [/SUP], Emanuel Wyler[SUP] 5 [/SUP], Luiz Gustavo Teixeira Alves[SUP] 5 [/SUP], Markus Landthaler[SUP] 5 6 [/SUP], Peter Ahnert[SUP] 3 [/SUP], Norbert Suttorp[SUP] 2 [/SUP], Martin Witzenrath[SUP] 2 7 [/SUP], Markus Scholz[SUP] 3 [/SUP]



Affiliations
Free article Abstract

When infected with SARS-CoV-2, Syrian hamsters (Mesocricetus auratus) develop moderate disease severity presenting key features of human COVID-19. We here develop a biomathematical model of the disease course by translating known biological mechanisms of virus-host interactions and immune responses into ordinary differential equations. We explicitly describe the dynamics of virus population, affected alveolar epithelial cells, and involved relevant immune cells comprising for example CD4+ T cells, CD8+ T cells, macrophages, natural killer cells and B cells. We also describe the humoral response dynamics of neutralising antibodies and major regulatory cytokines including CCL8 and CXCL10. The model is developed and parametrized based on experimental data collected at days 2, 3, 5, and 14 post infection. Pulmonary cell composition and their transcriptional profiles were obtained by lung single-cell RNA (scRNA) sequencing analysis. Parametrization of the model resulted in a good agreement of model and data. The model can be used to predict, for example, the time course of the virus population, immune cell dynamics, antibody production and regeneration of alveolar cells for different therapy scenarios or after multiple-infection events. We aim to translate this model to the human situation in the future.

Keywords: B cells; CCL8; CXCL10; Immune response; Macrophages; Mathematical model; Natural killer cells; Neutralising antibodies; SARS-CoV-2; T-cells.

 
Back
Top Bottom